Industry

Event will feature presentations from community opinion leaders and PharmaEssentia’s senior leadership team BURLINGTON, Mass.–(BUSINESS WIRE)–PharmaEssentia USA Corporation (PEC USA), a subsidiary of PharmaEssentia Corporation (TPEx:6446), a global biopharmaceutical innovator leveraging deep expertise and proven scientific principles to deliver new biologics in hematology and oncology, announced that it will host an Investor Day on Wednesday, … [Read more…]

  BOSTON–(BUSINESS WIRE)–#disruptivetechnology—New View Surgical, Inc., an emerging medical device company developing proprietary imaging and access technologies for minimally invasive surgery (MIS), today announced the closure of a $12.1M Series B-1 equity financing round to fund the commercialization of its VisionPort™ System. The company expects to launch the VisionPort System in the US before the … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Wearable Patch Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” report has been added to ResearchAndMarkets.com’s offering. The global wearable patch market size reached US$ 10.4 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 17.9 Billion by 2027, exhibiting a CAGR of 9.47% during 2021-2027. … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Mycoplasma Testing Market Size, Share & Trends Analysis by Product (Instruments, Kit & Reagents), by Technology (PCR, ELISA), by Application (Cell Line Testing, Virus Testing), by End Use, Region and Segment Forecasts, 2022-2030” report has been added to ResearchAndMarkets.com’s offering. The global mycoplasma testing market size is expected to reach USD 2.2 billion … [Read more…]

CANTON, Mich.–(BUSINESS WIRE)–#biotech–MMS Holdings, a data-focused contract research organization (CRO), has been named a 2022 award winner of the Michigan Top Workplaces by the Detroit Free Press Top Workplaces. This is the second year that MMS has been recognized with this honor. This award is based on feedback from a confidential survey sent out to … [Read more…]

Survival data from DESTINY-Breast03 and DESTINY-Breast02 phase 3 trials in patients with HER2 positive metastatic breast cancer further confirms efficacy of ENHERTU First presentation of datopotamab deruxtecan results in patients with HR positive, HER2 negative metastatic breast cancer shows promising clinical activity Annual R&D Day following SABCS to provide updates across Daiichi Sankyo R&D portfolio … [Read more…]

The VR fitness app introduces new jams in its workouts to get the heart a’thumping NEW YORK & LONDON–(BUSINESS WIRE)–FitXR, the leading VR fitness app, is introducing four new music collections, each featuring a series of workout classes with themed music in its Box, HIIT and Dance studios. The 80’s & 90’s Favorites Collection will … [Read more…]

PROVO, Utah & SEATTLE–(BUSINESS WIRE)–Qualtrics (Nasdaq: XM), the leader and creator of the experience management category, today announced that dozens of leading healthcare organizations, including Ascension and Intermountain Healthcare, selected Qualtrics solutions in the third quarter of 2022. By adopting technology to better understand patients, caregivers and staff – not just their experience in receiving … [Read more…]

Abstracts presented at the American College of Rheumatology (ACR) annual meeting demonstrate exciting results for digital therapeutics Swing Care launches in Texas to focus on virtual treatment of fibromyalgia patients SAN FRANCISCO–(BUSINESS WIRE)–Swing Therapeutics, a digital therapeutics company developing evidence-backed treatments for autoimmune and chronic pain conditions, today announced the presentation of research supporting the … [Read more…]

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Graphite Bio, Inc. (Nasdaq: GRPH), a clinical-stage, next-generation gene editing company harnessing the power of high-efficiency precision gene repair to develop therapies with the potential to treat or cure serious diseases, today announced that members of the management team will participate in a fireside chat at the Evercore ISI 5th Annual … [Read more…]